chr5-63960718-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_000524.4(HTR1A):c.1002G>A(p.Lys334Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000121 in 1,614,260 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00059 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000073 ( 0 hom. )
Consequence
HTR1A
NM_000524.4 synonymous
NM_000524.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.28
Genes affected
HTR1A (HGNC:5286): (5-hydroxytryptamine receptor 1A) This gene encodes a G protein-coupled receptor for 5-hydroxytryptamine (serotonin), and belongs to the 5-hydroxytryptamine receptor subfamily. Serotonin has been implicated in a number of physiologic processes and pathologic conditions. Inactivation of this gene in mice results in behavior consistent with an increased anxiety and stress response. Mutation in the promoter of this gene has been associated with menstrual cycle-dependent periodic fevers. [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 5-63960718-C-T is Benign according to our data. Variant chr5-63960718-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2655489.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=1.28 with no splicing effect.
BS2
High AC in GnomAd4 at 90 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000591 AC: 90AN: 152258Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
90
AN:
152258
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000139 AC: 35AN: 250950 AF XY: 0.000147 show subpopulations
GnomAD2 exomes
AF:
AC:
35
AN:
250950
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000725 AC: 106AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.0000536 AC XY: 39AN XY: 727240 show subpopulations
GnomAD4 exome
AF:
AC:
106
AN:
1461884
Hom.:
Cov.:
31
AF XY:
AC XY:
39
AN XY:
727240
Gnomad4 AFR exome
AF:
AC:
66
AN:
33480
Gnomad4 AMR exome
AF:
AC:
3
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26136
Gnomad4 EAS exome
AF:
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
AC:
0
AN:
86258
Gnomad4 FIN exome
AF:
AC:
0
AN:
53416
Gnomad4 NFE exome
AF:
AC:
23
AN:
1112006
Gnomad4 Remaining exome
AF:
AC:
14
AN:
60396
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000591 AC: 90AN: 152376Hom.: 0 Cov.: 33 AF XY: 0.000591 AC XY: 44AN XY: 74510 show subpopulations
GnomAD4 genome
AF:
AC:
90
AN:
152376
Hom.:
Cov.:
33
AF XY:
AC XY:
44
AN XY:
74510
Gnomad4 AFR
AF:
AC:
0.00209104
AN:
0.00209104
Gnomad4 AMR
AF:
AC:
0.0000653168
AN:
0.0000653168
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.0000293953
AN:
0.0000293953
Gnomad4 OTH
AF:
AC:
0
AN:
0
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Sep 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
HTR1A: BP4, BP7 -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at